Potentiation of in vivo model murine tumor destruction by combined immunoradiotherapy.
D000818:Animals; D000951:Antigens, Neoplasm / Q000008:administration & dosage*; D002453:Cell Cycle / Q000528:radiation effects; D002470:Cell Survival / Q000528:radiation effects; D004273:DNA, Neoplasm / Q000378:metabolism; D000939:Epitopes; D005260:Female; D007109:Immunity; D007167:Immunotherapy; D007700:Kinetics; D007942:Leukemia, Experimental / Q000276:immunology / Q000378:metabolism / Q000628:therapy*; D051379:Mice; D008810:Mice, Inbred C57BL
D000951:Antigens, Neoplasm; D004273:DNA, Neoplasm; D000939:Epitopes